{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-148922","form_type":"8-K","ticker":"SPRY","cik":"0001671858","company_name":"ARS Pharmaceuticals, Inc.","filed_at":"2025-06-26T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.284259+00:00","generated_at":"2026-05-18T17:58:29.325137+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"ARS Pharma stockholders elect four Class II directors, ratify Ernst & Young as auditor","bullets":["Elect directors Richard Lowenthal, Peter Kolchinsky, Brenton Saunders, Peter Thompson to 2028 term.","Lowenthal receives 64.9M votes for, 3.0M withheld; Kolchinsky 55.8M for, 12.1M withheld.","Saunders gets 56.2M for, 11.8M withheld; Thompson gets 61.8M for, 6.1M withheld.","Broker non-votes on director election: 9.6M shares for each nominee.","Auditor ratification passes with 77.3M for, 0.2M against; no broker non-votes."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-148922","json":"https://secwatch.observer/filing/0001193125-25-148922.json","markdown":"https://secwatch.observer/filing/0001193125-25-148922.md","text":"https://secwatch.observer/filing/0001193125-25-148922.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1671858/000119312525148922/0001193125-25-148922-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1671858/000119312525148922/d15622d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T17:58:29.325137+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}